December 17, 2024, 9AM PT
Liver health experts Dr. Naim Alkhouri and patient advocate Michael Betel share highlights and key insights from the world’s leading forum on liver disease!
Expand your knowledge.
Learn about the latest advances in assessing and managing liver disease, featuring key opinion leaders and subject matter experts.
Liver health experts Dr. Naim Alkhouri and patient advocate Michael Betel share highlights and key insights from the world’s leading forum on liver disease!
Join Key Opinion Leader and renowned endocrinologist Dr. Kenneth Cusi for an informative webinar that will unpack the relationship between diabetes and fatty liver disease.
Listen to expert panel Dr. Stephen Harrison, Dr. Maru/Mary Rinella, and Dr. Mazen Noureddin as they discuss the practical implications of a NASH drug approval.
Discover how recent advancements in NITs and NASH therapeutics could change the landscape of the disease.
Listen to Key Opinion Leader Dr. Naim Alkhouri to learn about alternative therapies that can help your NASH patients with metabolic disorders.
Learn about novel tools for assessing and managing patients with metabolic syndrome in your practice.
Discover how providers and payers can work together to address the emerging fatty liver disease epidemic, resulting in better patient outcomes with improved reimbursement.
Learn how a multidisciplinary approach will provide an optimal model of care for fatty liver disease patients.
Learn about the trends shaping the future of GI, and how you can leverage these trends to grow your GI practice.
Learn about promising therapies on the horizon to manage and treat NASH and the role of non-invasive tests.
Julia PinterMarketing Director
Julia Pinter brings over a decade of medical technology marketing experience spanning product commercialization, launch strategy, and sales enablement. Prior to joining Sonic Incytes, she served as Director of Global GI Product Marketing at PENTAX Medical, where she led global downstream marketing for the company’s largest portfolio — driving commercial launches of next-generation endoscopes, imaging systems, and AI platforms across the Americas, Europe, and Asia-Pacific. At Sonic Incytes, Julia leads downstream marketing initiatives to expand awareness and accelerate adoption of Velacur One®, translating its clinical and economic value into programs that support broader adoption of non-invasive liver assessment.